Monoclonal Antibodies Will Lead New Domestic Biopharma "Gold Rush"
This article was originally published in PharmAsia News
Executive Summary
Although the Chinese government is renewing broad support of emerging industries, analysts said particular attention and support will be given to the biopharma industry